CN
|
EN
Home
Introduction to the 2024 CBIIC
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Previous Speakers
News
Expert
Organizations
Service
Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Non-Listed Company Roadshow
Agendas
9:00 - 12:20
非上市公司路演专场
Non-Listed Company Roadshow
Moderator
汤泰萌 , 西南证券股份有限公司医药行业高级分析师
TANG Taimeng , Healthcare Senior Analysist of Southwest Securities
9:00 - 9:20
项目1
Project 1
ABM1310-新型透脑BRAF抑制剂在成人实体瘤中的多中心开放标签中美I期临床试验
A Phase 1 Multicenter, Open-Label Study of A New BRAF Inhibitor ABM-1310 in Adult Patients With BRAF-Mutated Solid Tumors
陈晨 璧辰医药创始人/董事长/CEO
CHEN Chen , Founder/Chairperson/CEO, ABM Therapeutics
9:20 - 9:40
项目2
Project 2
新一代微生物疗法开发平台
Innovative Microbial Therapeutics Development Platform
蒋先芝 慕恩(广州)生物科技有限公司创始人、总经理
JIANG Xianzhi , Founder & CEO, MoonBiotech
9:40 - 10:00
项目3
Project 3
基于长效重组人血清白蛋白融合蛋白平台的生物创新药
Bioinnovative Drugs Based on Long-Term Recombinant Human Serum Albumin Fusion Protein Platform
杨京生 华通福源生物技术(北京)股份有限公司总经理
YANG Jingsheng , CEO, Huatong FortuneRock (China) Co., Ltd.
10:00 - 10:20
项目4
Project 4
原创广谱抗炎药——伊匹乌肽
Original Broad-Spectrum Anti-Inflammatory Drug-Epivotide
夏献民 武汉益承生物科技有限公司总经理
XIA Xianmin , General Manager, Wuhan Yicheng Biotechnology Co., Ltd.
10:20 - 10:40
项目5
Project 5
甫康药业;差异化临床策略+创新合作商业策略,打造确定性更强的创新药企业成长路径
Convalife; Success in Clinical, Success in Sales
沈孝坤 甫康(上海)健康科技有限责任公司首席执行官
Steve SHEN , CEO, Convalife Pharmaceuticals Co., Ltd.
10:40 - 11:00
项目6
Project 6
星曜坤泽——致力于肝病领域未满足的临床需求
Hepa Thera - Committed to the Innovative Treatment of Unmet Clinical Needs in the Field of Liver Disease
马彦琴 苏州星曜坤泽生物制药有限公司执行总裁
Sophy MA , CEO, Suzhou Hepa Thera Biopharmaceutical Co., Ltd.
11:00 - 11:20
项目7
Project 7
靶向离子通道的治疗神经系统疾病创新药物
Innovative Drugs Targeting Ion Channels for Treating Neurological Diseases
毛声俊 成都新睿泰康科技有限公司总经理
MAO Shengjun , General Manager, Chengdu New Insights and Health Science Technology Co., Ltd.
11:20 - 11:40
项目8
Project 8
应用合成生物学开发口服生物创新药
Development of Oral Biological Medicines Using Synthetic Biology
高世宏 武汉康复得生物科技股份有限公司副总经理
GAO Shihong , Vice General Manager, Wuhan Kangfude Biotechnology Co., Ltd.
11:40 - 12:00
项目9
Project 9
博奥明赛——专注于全人源纳米双抗研发的临床公司
Biomissile-A Clinical Stage Company Focusing on Developing Fully Human Domain Antibody (UDAB
TM
) and Multi-specific Antibody (UDAB-M
TM
)
王敏 博奥明赛生物制药有限公司商务发展副总裁
Winnie WANG , BD VP, Biomissile Pharmaceuticals Co., Ltd.
12:00 - 12:20
项目10
Project10
聚焦解除肿瘤免疫微环境中抑制因子,实现“冷肿瘤”向“热肿瘤”转换
Turning “Cold” Tumors “Hot” by Removing Immune Suppressive Factors in the TME
秦续科 科望医药首席医学官
Steve CHIN , CMO, Elpiscience Biopharma, Ltd.